Today, P&G shared its intention to acquire Thorne, a leading science-driven wellness company known for its high-quality supplements and personalized health solutions backed by health care practitioners.
The acquisition would expand P&G Health Care’s ability to meet growing consumer interest in self-care, prevention and personalized wellness — areas where trusted science, product quality and practitioner credibility increasingly matter.
“Thorne has built a highly trusted brand at the forefront of personalized health,” said Paul Gama, Chief Executive Officer, Health Care. “Together, we see an opportunity to bring Thorne’s science-backed wellness solutions to more consumers while continuing to build on the quality, credibility and innovation that have made the brand successful.”
Thorne has earned a strong reputation with consumers, health care practitioners and professional partners through its commitment to scientific rigor, product quality and innovation. These strengths make Thorne a complementary fit with P&G’s Health Care portfolio and our commitment to helping consumers improve everyday health and well-being.
The transaction is subject to customary closing conditions, including regulatory approvals. Closing is expected later in calendar year 2026.
Learn more about Thorne here.
